1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, August 2016 (p10)

Drug Discovery and Development Analysis & Statistics, August 2016 (p10)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

271-300 of about 2400 reports

Purchase Reports From Reputable Market Research Publishers

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2016

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Onychomycosis (Tinea Unguium) Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Therapy, Healthcare
  • Countries : World
Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials ...

  • Industries : Drug Discovery and Development, Pathology, Biopharmaceutical, Pharmaceutical, Therapy, Biotechnology
  • Countries : World
Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Muckle-Wells ...

  • Industries : Drug Discovery and Development
  • Countries : World
Portal Hypertension - Pipeline Review, H2 2016

Portal Hypertension - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Portal Hypertension - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Portal Hypertension - Pipeline Review, H2 2016’, provides an overview of the Portal Hypertension pipeline landscape. ...

  • Industries : Pathology, Chronic Disease, Therapy, Pharmaceutical
  • Countries : United States
Ocular Pain - Pipeline Review, H2 2016

Ocular Pain - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Ocular Pain - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Ocular Pain - Pipeline Review, H2 2016’, provides an overview of the Ocular Pain pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Pharmaceutical, Therapy, Healthcare, General Medicine and Specialty Medicine
  • Countries : United States
Open-Angle Glaucoma - Pipeline Review, H2 2016

Open-Angle Glaucoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Open-Angle Glaucoma - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H2 2016’, provides an overview of the Open-Angle Glaucoma pipeline landscape. ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Healthcare
  • Countries : United States, World
Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline Review, H2 2016

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Ileal Sodium/Bile Acid Cotransporter (Apical Sodium Dependent Bile Acid Transporter or ASBT or Sodium/Taurocholate Cotransporting Polypeptide Ileal or Solute Carrier Family 10 Member 2 or SLC10A2) - Pipeline ...

  • Industries : Pathology
  • Countries : United States, World
Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 7 (Apoptotic Protease Mch ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H2 2016

Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 6 (Apoptotic Protease Mch 2 or CASP6 or EC 3.4.22.59) - Pipeline Review, ...

  • Industries : Pathology, Pharmaceutical, Drug Discovery and Development
  • Countries : World, United States
Anterior Uveitis - Pipeline Review, H2 2016

Anterior Uveitis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Anterior Uveitis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Anterior Uveitis - Pipeline Review, H2 2016’, provides an overview of the Anterior Uveitis pipeline landscape. The report ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Liver Cirrhosis - Pipeline Review, H2 2016

Liver Cirrhosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Liver Cirrhosis - Pipeline Review, H2 2016’, provides an overview of the Liver Cirrhosis pipeline landscape. The report ...

  • Industries : Pathology
  • Countries : United States
Polycystic Ovarian Syndrome - Pipeline Review, H2 2016

Polycystic Ovarian Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Polycystic Ovarian Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Polycystic Ovarian Syndrome - Pipeline Review, H2 2016’, provides an overview of the Polycystic Ovarian Syndrome ...

  • Industries : Pathology, Therapy
  • Countries : World, United States
Diabetic Gastroparesis - Pipeline Review, H2 2016

Diabetic Gastroparesis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Diabetic Gastroparesis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Diabetic Gastroparesis - Pipeline Review, H2 2016’, provides an overview of the Diabetic Gastroparesis pipeline ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Thalassemia Global Clinical Trials Review, H2, 2016

Thalassemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Thalassemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2016" provides an overview of Thalassemia clinical trials ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Healthcare
  • Countries : World
Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016’, provides in depth ...

  • Industries : Therapy, Cancer, Pathology, Biotechnology, Biopharmaceutical, Drug Discovery and Development
  • Countries : United States
Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016

Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Malignant Pleural Mesothelioma Global Clinical Trials Review, H2, 2016" provides an ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World
Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer
  • Countries : World
Mycosis Fungoides Global Clinical Trials Review, H2, 2016

Mycosis Fungoides Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Mycosis Fungoides Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides ...

  • Industries : Cancer, Pathology, Drug Discovery and Development
  • Countries : World, United States
Malignant Ascites Global Clinical Trials Review, H2, 2016

Malignant Ascites Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Malignant Ascites Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Ascites ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World
Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology, Therapy
  • Countries : World
T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World, United States
T-Cell Leukemia Global Clinical Trials Review, H2, 2016

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

T-Cell Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States
Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, ...

  • Industries : Cancer, Pathology, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Clinical Trial Data Management Services - Industry Market Research Report

Clinical Trial Data Management Services - Industry Market Research Report

  • $ 1020
  • Industry report
  • August 2016
  • by Ibisworld

Input data: A growing healthcare sector and rising private investment will boost industry revenue Clinical Trial Data Management Services The Clinical Trial Data Management Services industry specializes ...

  • Industries : Software
  • Countries : United States
Global Lab Automation in Drug Discovery Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

Global Lab Automation in Drug Discovery Market Segmented by Type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2016 - 2021)

  • $ 4250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The emergence of robotics has transformed the typical workday for scientists around the world. With the advent of automation techniques, scientists are now able to set up, run, and analyze the results ...

  • Industries : Drug Discovery and Development
Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026

Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026

  • $ 2349
  • Industry report
  • August 2016
  • by Roots Analysis Private Ltd.

An imbalance in the production and / or drainage of aqueous humor within the eye is known to lead to an increase in intraocular pressure (IOP). Acutely elevated IOP, a condition broadly known as ocula ...

  • Industries : General Medicine and Specialty Medicine, Pathology, Pharmaceutical, Healthcare
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.